Pages that link to "Item:Q3299101"

The following pages link to An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints (Q3299101):

Displaying 7 items.

• Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials (Q1727847) (← links)
• Efficacy and toxicity monitoring via Bayesian predictive probabilities in phase II clinical trials (Q2059113) (← links)
• Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome (Q3465385) (← links)
• Bayesian Optimal Design for Phase II Screening Trials (Q3530110) (← links)
• Bayesian design of biosimilars clinical programs involving multiple therapeutic indications (Q5128840) (← links)
• A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes (Q6076490) (← links)
• A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints (Q6625443) (← links)